{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:10:11Z","timestamp":1778314211343,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"FACEPE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bbr.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T21:45:51Z","timestamp":1454535951000},"page":"168-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Evidence for involvement of NK3 receptors in the anxiogenic-like effect of SP6-11(C-terminal), a metabolite of substance P, in rats evaluated in the elevated plus-maze"],"prefix":"10.1016","volume":"303","author":[{"given":"Filipe Silveira","family":"Duarte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Duzzioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Rinaldi","family":"Leme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saulo de Paiva","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thereza C.M.","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","article-title":"Neurotransmitter functions of mammalian tachykinins","volume":"73","author":"Otsuka","year":"1993","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00023210-200519040-00001","article-title":"Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential","volume":"19","author":"Herpfer","year":"2005","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2011.09.007","article-title":"Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases?","volume":"133","author":"Griebel","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0031-6997(25)06810-3","article-title":"Receptors and antagonists for substance P and related peptides","volume":"46","author":"Regoli","year":"1994","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(96)00390-1","article-title":"Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice","volume":"311","author":"Teixeira","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.02.003_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1054\/npep.1999.0021","article-title":"Tachykinin NK3 receptor involvement in anxiety","volume":"33","author":"Ribeiro","year":"1999","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.bbr.2016.02.003_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1054\/npep.2000.0834","article-title":"Neuroanatomical localisation of substance P in the CNS and sensory neurons","volume":"34","author":"Ribeiro-da-Silva","year":"2000","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0196-9781(84)90056-1","article-title":"Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites","volume":"5","author":"Hall","year":"1984","journal-title":"Peptides"},{"issue":"1\u20133","key":"10.1016\/j.bbr.2016.02.003_bib0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0304-3940(88)90671-4","article-title":"Substance P(1-7) antagonizes substance P-induced aversive behaviour in mice","volume":"95","author":"Sakurada","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2016.02.003_bib0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0306-4522(90)90003-3","article-title":"Role of substance P aminoterminal metabolites in substance P-induced desensitization in mice","volume":"36","author":"Igwe","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2016.02.003_bib0055","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1523\/JNEUROSCI.10-04-01309.1990","article-title":"Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception","volume":"10","author":"Skilling","year":"1990","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbr.2004.03.020","article-title":"Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats","volume":"154","author":"Duarte","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0065","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0026-895X(25)09261-2","article-title":"Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors","volume":"41","author":"Cascieri","year":"1992","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-008-1434-y","article-title":"Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats","volume":"204","author":"Bassi","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0028-3908(00)00149-0","article-title":"Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study","volume":"40","author":"Langlois","year":"2001","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(00)00228-7","article-title":"Localization of NK1 and NK3 receptors in guinea-pig brain","volume":"98","author":"Yip","year":"2001","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.bbr.2016.02.003_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.31887\/DCNS.2002.4.3\/tsteimer","article-title":"The biology of fear- and anxiety-related behaviors","volume":"4","author":"Steimer","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrn3945","article-title":"Neuronal circuits for fear and anxiety","volume":"16","author":"Tovote","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2016.02.003_bib0095","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02244851","article-title":"Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol","volume":"114","author":"Cole","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze","volume":"21","author":"Rodgers","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bbr.2016.02.003_bib0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0100-879X1997000300002","article-title":"Animal models of anxiety: an ethological perspective","volume":"30","author":"Rodgers","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bbr.2016.02.003_bib0115","first-page":"1696","article-title":"Behavioral effects of intracerebroventricular injection of selective tachykinin agonists and antagonists","volume":"21","author":"De Lima","year":"1995","journal-title":"Soc. Neurosci. Abstr."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(90)90563-W","article-title":"Phosphoramidon potentiates mammalian tachykinin-induced biting, licking and scratching behaviour in mice","volume":"37","author":"Sakurada","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0166-4328(02)00054-2","article-title":"The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P","volume":"134","author":"Gavioli","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(00)00229-1","article-title":"Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze","volume":"114","author":"Wall","year":"2000","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0006-8993(87)90242-3","article-title":"Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence","volume":"420","author":"Hall","year":"1987","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0196-9781(89)90132-0","article-title":"The role of enzymatic processing in the biological actions of substance P","volume":"10","author":"Hall","year":"1989","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0143-4179(98)90080-4","article-title":"Substance P fragments and striatal endogenous dopamine outflow: interaction with substance P","volume":"32","author":"Khan","year":"1998","journal-title":"Neuropeptides"},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0150","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/oxfordjournals.jbchem.a122599","article-title":"Purification and characterization of a substance P-degrading endopeptidase from rat brain","volume":"104","author":"Endo","year":"1988","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.bbr.2016.02.003_bib0155","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1471-4159.1995.64031312.x","article-title":"The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin","volume":"64","author":"Backstrom","year":"1995","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1054\/npep.2000.0840","article-title":"The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor","volume":"35","author":"Vigna","year":"2001","journal-title":"Neuropeptides"},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0165","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0006-8993(90)91226-7","article-title":"Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments","volume":"526","author":"Reid","year":"1990","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0006-8993(95)00577-D","article-title":"Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats","volume":"690","author":"Tschope","year":"1995","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.bbr.2016.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0196-9781(99)00154-0","article-title":"Anxiogenic effects of substance P and its 7-11C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray","volume":"20","author":"De Araujo","year":"1999","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.bbr.2016.02.003_bib0180","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0022-3565(24)36725-4","article-title":"Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist","volume":"281","author":"Sarau","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"19","key":"10.1016\/j.bbr.2016.02.003_bib0185","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/0024-3205(87)90050-6","article-title":"Modulation of blood pressure by substance P: opposite effects of N- and C- terminal fragments on anesthetized rats","volume":"40","author":"Hall","year":"1987","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbr.2016.02.003_bib0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0196-9781(83)90033-5","article-title":"Substance P and behavior: opposite effects of N-terminal and C-terminal fragments","volume":"4","author":"Hall","year":"1983","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0006-8993(90)91558-X","article-title":"The substance P(1-7) fragment is a potent modulator of substance P actions in the brain","volume":"521","author":"Herrera-Marschitz","year":"1990","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-3565(25)38933-0","article-title":"An antinociceptive effect of capsaicin in the adult mouse mediated by the NH2-terminus of substance P","volume":"268","author":"Mousseau","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389203033380313","article-title":"Neuropeptide conversion to bioactive fragments\u2014an important pathway in neuromodulation","volume":"4","author":"Hallberg","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbr.2016.02.003_bib0215","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/jm00228a028","article-title":"Biological activity of C-terminal partial sequences of substance P","author":"Bury","year":"1976","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)00902-2","article-title":"Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P","volume":"283","author":"Nikolaus","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"2\u20133","key":"10.1016\/j.bbr.2016.02.003_bib0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(98)00441-5","article-title":"Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region","volume":"354","author":"Hasen\u00f6hrl","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.bbr.2016.02.003_bib0230","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867043364748","article-title":"Tachykinins and tachykinin receptors: structure and activity relationships","volume":"11","author":"Almeida","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0235","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1471-4159.1993.tb03484.x","article-title":"Tachykinin receptors: a radioligand binding perspective","volume":"60","author":"Mussap","year":"1993","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(94)00681-V","article-title":"Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices","volume":"273","author":"Seabrook","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2016.02.003_bib0245","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-3565(25)20335-4","article-title":"Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells","volume":"259","author":"Ingi","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.bbr.2016.02.003_bib0250","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1016\/S0021-9258(18)53041-6","article-title":"Chimeric NK1 (substance P)\/NK3 (neurokinin B) receptors: identification of domains determining the binding specificity of tachykinin agonists","volume":"268","author":"Gether","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1096-9861(19960108)364:2<290::AID-CNE8>3.0.CO;2-0","article-title":"Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat","volume":"364","author":"Ding","year":"1996","journal-title":"J. Comp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-8993(90)91015-9","article-title":"Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT","volume":"517","author":"Stoessl","year":"1990","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0265","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1046\/j.1471-4159.1995.65062543.x","article-title":"Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study","volume":"65","author":"Steinberg","year":"1995","journal-title":"J. Neurochem."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2016.02.003_bib0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(92)91674-4","article-title":"The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats","volume":"592","author":"Boix","year":"1992","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2016.02.003_bib0275","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0006-8993(91)91657-M","article-title":"Behavioural effects of selective tachykinin agonists in midbrain dopamine regions","volume":"565","author":"Stoessl","year":"1991","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(95)00791-N","article-title":"Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine","volume":"695","author":"Bannon","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2016.02.003_bib0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(98)00880-5","article-title":"Related naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice","volume":"258","author":"Ribeiro","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.bbr.2016.02.003_bib0290","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.euroneuro.2010.11.010","article-title":"Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus","volume":"21","author":"Schable","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0295","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pbb.2006.03.013","article-title":"Selective blockade of NK2 or NK3 receptors produces anxiolytic- and antidepressant-like effects in gerbils","volume":"83","author":"Salome","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.02.003_bib0300","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2014.06.006","article-title":"NK\u2083 receptor agonism reinstates temporal order memory in the hemiparkinsonian rat","volume":"285","author":"Chao","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"37","key":"10.1016\/j.bbr.2016.02.003_bib0305","doi-asserted-by":"crossref","first-page":"15097","DOI":"10.1073\/pnas.1306884110","article-title":"Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism","volume":"110","author":"De Souza Silva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbr.2016.02.003_bib0310","first-page":"PL27","article-title":"SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor","volume":"56","author":"Emonds-Alt","year":"1995","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bbr.2016.02.003_bib0315","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bjp.0701435","article-title":"Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat","volume":"122","author":"Cellier","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2016.02.003_bib0320","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1034\/j.1399-3011.2002.01977.x","article-title":"Analogs of substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway","volume":"59","author":"Sachon","year":"2002","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.bbr.2016.02.003_bib0325","first-page":"811","article-title":"Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals","volume":"27","author":"Graeff","year":"1994","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"12","key":"10.1016\/j.bbr.2016.02.003_bib0330","first-page":"2759","article-title":"Neuroanatomical and neurochemical mechanisms underlying amygdaloid control of defensive rage behavior in the cat","volume":"27","author":"Shaikh","year":"1994","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816300614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816300614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:02:56Z","timestamp":1748768576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816300614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":66,"alternative-id":["S0166432816300614"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.02.003","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for involvement of NK3 receptors in the anxiogenic-like effect of SP6-11(C-terminal), a metabolite of substance P, in rats evaluated in the elevated plus-maze","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}